Early Intervention in Cerebral Palsy: Perception-Action vs Neurodevelopmental Therapy
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6-36
SponsorTuba Derya Doğan
About this trial
The goal of this clinical trial is to compare two different physiotherapy approaches used in early intervention for children with cerebral palsy. These approaches are the Perception-Action Approach and Neurodevelopmental Therapy (Bobath). The study aims to understand which approach is more effective in supporting neurodevelopmental outcomes in early childhood in Cerebral Palsy.
The main questions this study aims to answer are:
How does the Perception-Action Approach affect motor function in young children with cerebral palsy? How does Neurodevelopmental Therapy (Bobath) affect motor function in young children with cerebral palsy? Are there differences in outcomes between these two approaches?
Researchers will compare these two approaches to see which one better supports motor development.
Participants will:
Be children aged 0 to 36 months with cerebral palsy or at high risk Be assigned to one of the two therapy groups Receive one therapy session per week for 12 weeks Be assessed before and after the intervention using standardized tests
The results of this study may help therapists and families choose the most effective early intervention approach for children with cerebral palsy.
Eligibility criteria
Qualifiers
Diagnosis of Cerebral Palsy
Being at high risk for Cerebral Palsy (based on MRI or cranial ultrasound findings and neurological examination)
Age between 0-36 months (using corrected age for preterm infants)
Parental agreement to participate in the study and attend all assessment and therapy sessions; signed informed consent form from the parent(s) or legal guardian(s)
Disqualifiers
Presence of severe visual or hearing impairment that would prevent full participation in therapy sessions
Uncontrolled seizures
Receipt of botulinum toxin injection or orthopedic surgery within the last 6 months
Diagnosis of an additional neurometabolic, genetic, or other neurological disorder
Trial design
Treatments tested in this trial
- Perception-Action Approach
- Neurodevelopmental Therapy (Bobath)
Treatment groups
24 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Tuba Derya Doğan
Lead sponsor
Istinye University
Sponsor institution
Source ClinicalTrials.gov